[xysoom]

Chinese Covid-19 Vaccine Efficacy Better than Expected Interview


On Jan.15th, China’s state media Zhongguo Jijian Jiancha Bao (China Disciplinary Supervision Newspaper) published the interview with Mr. Liu Jingzhen, Chairman of the state-owned China National Pharmaceutical Group (Sinopharm) on China’s first approved Covid-19 vaccine Sinopharm developed.To get more news about sinopharm covid vaccine, you can visit shine news official website.

On Dec.30th, 2020, the National Medical Products Administration granted conditional market approval to the Covid-19 vaccine developed by Sinopharm CNBG Beijing Institute. Before that, 5 countries had authorized emergency use for the said vaccine including China, the UAE, Bahrain, Egypt and Jordan. Abroad, over 10 heads of countries and government departments had received this vaccination. Up to now, over 50 countries had expressed the willingness to procure the vaccine.

Domestically, Sinopharm’s Covid-19 vaccines are being administered to priority groups of people in many places, with the number exceeding 1 million in Beijing and 602 thousand in Shanghai. Over 10 million doses have been administered across the nation.

Covid-19 vaccines are now having the world’s attention. Is the Chinese vaccine safe? How long is the protection duration? What is the information for the recipients? Is the vaccine still effective if the virus mutates? Mr. Liu Jingzhen, Chairman of Sinopharm, received our interview upon these questions.
Q: What is your point of view towards the necessity of vaccination given the current epidemic situation?

Liu Jingzhen: It is of great importance for preventing the epidemic to vaccinate the priority group of people at this winter-spring time. The State Council prevention and control mechanism takes two steps in the vaccination: first for the priority group who are those with higher risk of being exposed to the virus and those to work or study in the countries of medium-high risk of the pandemic; second is to vaccinate all eligible people when bigger quantity of vaccines are released to the market with the vaccine being approved or capacity being expanded.

Q: What is the information for the recipients of the vaccine?

Liu Jingzhen: The vaccination is based on voluntary informed consent. The recipient shall report his/her health condition truthfully to the medical workers. And the recipient should stay for another 30 minutes for observation after the jab as previous experience show that the adverse reaction, if any, is more likely to occur within 30 minutes after the injection.